Open | - |
Close | - |
Volume / Avg. | 2.000 / 760.988K |
Day Range | - - - |
52 Wk Range | 4.170 - 9.120 |
Market Cap | $793.367M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 6.32% |
Days to Cover | 3.43 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Exscientia (NASDAQ: EXAI) through any online brokerage.
Other companies in Exscientia’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), ARS Pharmaceuticals (NASDAQ:SPRY), Cogent Biosciences (NASDAQ:COGT) and Fusion Pharmaceuticals (NASDAQ:FUSN).
The latest price target for Exscientia (NASDAQ: EXAI) was reported by B of A Securities on Friday, January 5, 2024. The analyst firm set a price target for 9.00 expecting EXAI to rise to within 12 months (a possible 41.73% upside). 13 analyst firms have reported ratings in the last year.
The stock price for Exscientia (NASDAQ: EXAI) is $6.35 last updated March 18, 2024 at 6:23 PM EDT.
There are no upcoming dividends for Exscientia.
Exscientia’s Q1 earnings are confirmed for Wednesday, May 22, 2024.
There is no upcoming split for Exscientia.
Exscientia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.